Clinical Trial Update: The Effect of SLC19A3 Inhibition on the Pharmacokinetics of Thiamine [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the effect of SLC19A3 inhibition on the pharmacokinetics of thiamine in individuals with thiamine/Vitamin B1 deficiency; resul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thiamine Deficiency
• Vitamin B1 Deficiency

Drugs mentioned

• SLC19A3 inhibitor

Snippet

Sponsor: University of California, San Francisco | Conditions: Vitamin B1 Deficiency, Thiamine Deficiency | Phase 4 | Status: COMPLETED | Results posted: 2025-01-03